# OnCo record lmy-920 (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/lmy-920/>
  a schema:Drug ;
  onco:kind "drug" ;
  schema:identifier "lmy-920" ;
  schema:name "LMY-920"@en ;
  schema:alternateName "BAFF CAR-T"@en, "BAFF-L CAR T cells"@en ;
  schema:description "LMY-920 is an experimental CAR-T treatment from Luminary Therapeutics, made from a patient's own immune cells, aimed at three receptors on cancerous B cells. It is in early trials in lymphoma and myeloma."@en ;
  schema:url <https://onco.cc/drugs/lmy-920/> ;
  schema:dateModified "2026-11-04"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT05312801>, <https://clinicaltrials.gov/study/NCT05546723>, <https://www.luminarytx.com/pipeline/> ;
  onco:status "phase-1" ;
  onco:tag "pipeline" ;
  onco:modality "Autologous CAR-T cell therapy (BAFF ligand-based CAR)" ;
  onco:technologies <https://onco.cc/technologies/car-t/> ;
  onco:companies <https://onco.cc/companies/luminary-therapeutics/> .